In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Iovance Biotherapeutics (IOVA – Research ...

Truist Financial analyst Tobey Sommer maintained a Buy rating on Waste Management (WM – Research Report) today. The company’s shares closed ...

This was the stock's second consecutive day of gains.

Truist Securities upgraded Pacira Pharmaceuticals (NASDAQ:PCRX) stock rating from Hold to Buy, significantly raising the price target to $25.00 from the previous $8.00. The stock, currently trading at ...

Geneos Wealth Management Inc. boosted its position in shares of Truist Financial Co. (NYSE:TFC – Free Report) by 3.2% in the ...

Analysts at Truist Financial assumed coverage on shares of Tronox (NYSE:TROX – Get Free Report) in a research note issued to ...

Truist Financial on Friday exceeded Wall Street estimates for fourth-quarter profit, helped by stronger investment banking ...

Truist Securities confirmed its positive stance on Iovance Biotherapeutics (NASDAQ:IOVA) shares, maintaining a Buy rating and a price target of $25.00. With the stock currently trading at $6.07, this ...

Truist Financial Corp (TFC) stock saw a modest uptick, ending the day at $47 which represents a slight increase of $0.24 or 0.51% from the prior close of $46.76. The stock opened at $46.5 and touched ...

If the General Services Administration becomes a target for cost cuts, the shift could impact markets both within and outside ...

Money from the program will be used by nonprofit groups to help rebuild small businesses, housing and infrastructure in 39 ...

Truist Financial's Q4 beat EPS and revenue estimates, but noninterest expenses rose and specific lending segments faced ...